Bioresorbable Polymer Market to Hit US$ 3.10 Billion by 2031, Driven by 9.3% CAGR & 40% North America Dominance

The Global Bioresorbable Polymer Market reached US$ 1.52 billion in 2023 and is expected to reach US$ 3.10 billion by 2031, growing at a CAGR of around 9.3% during the forecast period 2024-2031. Growth is fueled by increasing adoption of bioresorbable medical devices, rising demand for controlled drug delivery systems, and expanding applications in orthopedic, cardiovascular, and tissue engineering procedures.

Polylactic acid (PLA) and polyglycolic acid (PGA) remain the most widely used polymers, holding the largest market share due to their strong biocompatibility and predictable degradation profile. North America dominates the global market, supported by advanced healthcare infrastructure and ongoing research in biodegradable implants, while Asia-Pacific is the fastest-growing region with rising surgical volumes and increasing investments in medical technology manufacturing. The shift toward minimally invasive and patient-friendly treatment solutions continues to accelerate market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioresorbable-polymer-market?sai-v

Bioresorbable Polymer Market refers to the industry that produces polymers capable of safely breaking down and being absorbed by the body, mainly used in medical implants, drug delivery systems, and tissue engineering applications.

Key Developments

United States
✅ January 2025: US medical device manufacturers increased adoption of bioresorbable polymers in orthopedic screws, vascular scaffolds, and drug-delivery components due to rising demand for minimally invasive procedures.

✅ April 2025: Leading US polymer producers expanded R&D investments into PLA, PGA, and PCL-based bioresorbable materials optimized for tissue engineering and regenerative medicine applications.

✅ August 2025: US biotech firms initiated clinical evaluations of next-generation bioresorbable stents with improved degradation profiles and enhanced biocompatibility, targeting cardiovascular and peripheral vascular applications.

Japan
✅ February 2025: Japanese material science companies developed ultra-pure medical-grade bioresorbable polymers formulated for ophthalmic implants and bioresorbable sutures.

✅ June 2025: Japan's research institutes advanced 3D-printed bioresorbable scaffold technology for bone and cartilage regeneration, integrating bioactive additives to accelerate tissue growth.

✅ September 2025: Leading Japanese chemical manufacturers expanded domestic production of bioresorbable polymer pellets to meet growing medical device export demand across APAC and Europe.

Mergers & Acquisitions

United States
✅ March 2025: A US-based medical materials company acquired a startup specializing in bioresorbable nanofiber technology to strengthen its portfolio for regenerative medicine.

✅ October 2025: An American polymer manufacturer entered a strategic collaboration with a global medical device company to co-develop bioresorbable components for cardiovascular and orthopedic implants.

Japan
✅ April 2025: A Japanese chemical corporation partnered with a domestic biomedical engineering firm to develop next-generation bioresorbable polymers for drug-eluting implantables.

✅ July 2025: A Japan-based life science company formed a joint venture with a European biomaterials developer to scale production of high-strength, controlled-degradation bioresorbable polymers.

Key Players
Corbion N.V. | Evonik Industries AG | Foster Corporation | KLS Martin Group | DSM Biomedical, Inc. | Ashland Global Holdings Inc. | Zeus Industrial Products, Inc. | Seqens Group | REVA Medical, LLC | Poly-Med Incorporated | Bezwada Biomedical, LLC | Nomisma Healthcare Pvt. Ltd | BMG Incorporated

Key Highlights
• Evonik Industries AG - Holds 17.4% share of the global bioresorbable polymers and biomaterials market, driven by strong demand for its RESOMER® portfolio used in drug delivery, implants, and tissue engineering.

• Corbion N.V. - Accounts for 15.8% market share, supported by its high-performance PLA/PLGA biomaterials used in medical implants and controlled-release applications.

• DSM Biomedical, Inc. - Maintains 13.2% share, propelled by advanced biomedical polymers, bioresorbable scaffolds, and customized material solutions for orthopedics and cardiovascular implants.

• Zeus Industrial Products, Inc. - Holds 11.1% share, driven by specialty polymer extrusions, bioresorbable tubing, and minimally invasive medical device components.

• Ashland Global Holdings Inc. - Controls 9.4% share, supported by its pharmaceutical-grade polymers used in drug delivery systems and biodegradable implant materials.

• Seqens Group - Contributes 7.9% share, backed by extensive custom polymer synthesis capabilities and bioresorbable material manufacturing.

• Foster Corporation - Holds 6.6% share, recognized for medical-grade polymer compounding and bioresorbable material solutions for implantable devices.

• KLS Martin Group - Represents 5.3% share, driven by bioresorbable plating systems and polymer-based cranio-maxillofacial implants.

• REVA Medical, LLC - Holds 4.7% share, supported by innovations in bioresorbable stent polymers and cardiovascular implant technologies.

• Poly-Med Incorporated - Accounts for 3.8% share, known for custom bioresorbable polymer synthesis and medical implant materials.

• Bezwada Biomedical, LLC - Holds 2.4% share, driven by specialized biodegradable polymers for sutures, adhesives, and scaffolds.

• Nomisma Healthcare Pvt. Ltd - Contributes 1.8% share, supported by emerging capabilities in polymer-based medical device materials.

• BMG Incorporated - Holds 1.6% share, driven by niche biodegradable polymer solutions for medical applications.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-polymer-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
• Growing demand for advanced biodegradable materials in medical implants, drug-delivery systems, and tissue engineering is driving adoption of bioresorbable polymers.

• Rising prevalence of orthopedic, cardiovascular, and dental procedures is boosting the need for temporary implant materials that safely dissolve in the body.

• Increasing shift toward minimally invasive surgeries supports the use of bioresorbable stents, sutures, anchors, and scaffolds.

• Heightened regulatory and patient preference for biocompatible and non-toxic materials is accelerating development of next-generation polymers.

• Expansion of regenerative medicine, stem cell research, and personalized therapies is creating new applications for bioresorbable scaffolds and matrices.

Industry Developments
• Leading medical device companies introduced new bioresorbable orthopedic fixation products with improved mechanical strength and controlled degradation rates.

• Polymer manufacturers expanded production of polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL) grades tailored for medical and pharmaceutical applications.

• Research collaborations developed bioresorbable vascular scaffolds with enhanced flexibility and reduced inflammation risk.

• Innovations in drug-delivery platforms using bioresorbable microspheres and hydrogels improved targeted and sustained release capabilities.

• Asia-based players increased investment in biodegradable polymer facilities to support growing medical device manufacturing.

Regional Insights
• North America holds a 40% share, driven by strong medical device innovation, widespread adoption of bioresorbable implants, and robust regulatory support for advanced biomaterials.

• Europe holds a 32% share, supported by high demand for biodegradable medical products, strong research infrastructure, and growing focus on next-generation cardiovascular and orthopedic solutions.

• Asia Pacific holds a 22% share, fueled by expanding healthcare infrastructure, rising surgical volumes, and increasing production of cost-effective bioresorbable polymers.

• Latin America holds a 4% share, driven by growing uptake of minimally invasive surgical technologies and increasing availability of advanced biomaterials.

• Middle East & Africa hold a 2% share, supported by rising healthcare modernization, increasing orthopedic procedures, and gradual adoption of biodegradable implants.

Key Segments:

➥ By Type
Polylactic Acid (PLA) leads the market due to its strong biodegradability, renewable sourcing, and wide acceptance in medical implants and drug-delivery systems. Polyglycolic Acid (PGA) is preferred for high-strength, fast-degrading applications such as sutures and tissue engineering. Poly(lactic-co-glycolic acid) (PLGA) is growing rapidly, supported by its tunable degradation rate and extensive use in controlled drug-release formulations. Polycaprolactone (PCL) offers slower degradation and high flexibility, making it suitable for long-term implants and 3D-printed biomedical scaffolds. Other biodegradable polymers continue to gain interest as research expands into novel medical-grade materials.

➥ By Form
Powder form dominates, widely used in additive manufacturing, tissue engineering, and formulation of drug-delivery particles. Tablet form finds strong application in controlled-release drug delivery, implantable devices, and biodegradable inserts. Other forms-including films, pellets, and scaffolds-support specialized uses across medical, pharmaceutical, and industrial applications.

➥ By Application
Drug delivery is the leading segment, driven by the need for biodegradable carriers that provide sustained and targeted release. Orthopedics is expanding rapidly, with biodegradable polymers used in screws, plates, fixation devices, and regenerative scaffolds. 3D-printing filaments are witnessing strong growth as hospitals, research centers, and manufacturers adopt biodegradable materials for patient-specific implants and biomedical prototyping. Other applications, such as wound care, tissue regeneration, and specialty medical devices, continue to broaden the market's scope.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioresorbable-polymer-market?sai-v

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.